By Amanda Gardner
EmpowHer's HealthDay Reporter
MONDAY, June 2 (HealthDay News) -- An experimental cancer vaccine is showing promise against the same general type of brain tumor diagnosed in Sen. Edward Kennedy, researchers are reporting.
The vaccine, when given with chemotherapy, more than doubled progression-free survival in patients with glioblastoma multiforme tumors. Kennedy was diagnosed last month with a malignant glioma, a class of brain tumor that includes glioblastoma, and underwent surgery Monday for the tumor.